Chris Sale is getting the anti-Strasburg treatment. And it tells us … nothing.

21 Comments

Jeff Passan talks with Chris Sale and the White Sox. While Stephen Strasburg was shut down at 159 and a third, the White Sox’ young arm is still going at 188.  No, Sale never had Tommy John surgery, but he had also never thrown more than 71 innings before this season.

It’s an interesting article, but not because it tells us which approach is right and which approach is wrong with a young starter. Indeed, try this little experiment: Read Passan’s article and check out the quotes from Don Cooper and everyone with the White Sox.  Then imagine a future where Sale is facing Tommy John surgery or worse and think how horribly they’ll play. Heck, they’ll be used at a capital trial of those pitching war criminals.  Do the same for Strasburg in relation to all of the cautious quotes from the Nats and their fans if Strasburg nonetheless gets hurt. Now reverse it, with both guys being healthy. You can take any and every possible lesson from it depending on the outcome.

The most interesting thing about it all is just how certain the White Sox are that they’re doing the right thing with Sale.  And how, earlier, the Nationals were just as certain that they were doing the right thing with Strasburg.  Sort of tells you that, no, no one has any freakin’ idea what the right thing is, the only validation, such as it is, that anyone will get is if either of those two get injured in the future, and even then we won’t know whether their treatment caused it, prevented it, was meaningless or not.

Mets acquire Brooks Pounders from Indians

Brooks Pounders
Getty Images
Leave a comment

The Mets have acquired right-handed reliever Brooks Pounders from the Indians for cash considerations, the teams reported Saturday. Despite his limited and varied major-league experience, Pounders has put up intriguing numbers at the Triple-A level and is expected to step into a not-insignificant role with the Mets’ relief corps.

Pounders, 28, signed a minor-league deal with the Indians last December and pitched to a healthy 2.31 ERA, 2.8 BB/8, and 11.8 SO/9 over his first 35 innings in Cleveland’s farm system. He hasn’t taken the mound in a major-league setting since 2018, however, when he appeared in 14 games with the Rockies and labored through a much more unsightly 7.63 ERA, 1.2 BB/9, and 10.0 SO/9 across 15 1/3 frames. Still, his peripherals are promising, and there’s no question the Mets could use some help bolstering a bullpen that currently ranks eighth-worst in the league with a collective 5.31 ERA and 0.2 fWAR.

In subsequent roster moves, fellow righty Tyler Bashlor was sent back to Triple-A Syracuse for the second time this season, while Héctor Santiago was designated for assignment, Tim Peterson was optioned to Triple-A, and Chris Flexen was recalled from Triple-A. It’s been a less-than-ideal campaign for Bashlor so far this year: through 13 relief appearances for the club, he lost control of a bloated 5.23 ERA, 5.4 BB/9, and 9.3 SO/9 in 11 2/3 innings and had not been utilized in a game since June 2.